C a Boucher - JoVE Visualize

Showing results (221-230 of 254) with videos related to

Pageof 26

Sort By:

AIDS (London, England)|April 1, 1993

Antigenic variation of the dominant gp41 epitope in AfricaJ M Lange, V J Teeuwsen, C A Boucher, et al.

AIDS (London, England)|July 24, 1998

Efficient inhibition of both syncytium-inducing and non-syncytium-inducing wild-type HIV-1 by lamivudine in vivoA B van 't Wout, L J Ran, M Nijhuis, et al.

AIDS (London, England)|November 1, 1992

HIV-1 biological phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatmentC A Boucher, J M Lange, F F Miedema, et al.

Antiviral Therapy|April 1, 1996

Tolerability and activity of a new recombinant interferon-alpha B/D hybrid in patients with HIV-1 infectionP H Frissen, K Brinkman, C H Ten Napel, et al.

The American Journal of Cardiology|February 15, 1987

Left ventricular ejection fraction response during exercise in asymptomatic systemic hypertensionD D Miller, T D Ruddy, R M Zusman, et al.

Journal of the American College of Cardiology|March 1, 1986

Determination of the quantitative thallium imaging variables that optimize detection of coronary artery diseaseS Kaul, C A Boucher, J B Newell, et al.

Circulation|August 1, 1981

The effect of pulsatile perfusion on preservation of left ventricular function after aortocoronary bypass graftingF H Levine, H R Phillips, J E Carter, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1980

The bifocal diverging collimator: a means of simultaneous biplane imaging of the heart during equilibrium radionuclide ventriculographyC A Boucher, H W Strauss, R D Okada, et al.

Circulation|January 1, 1985

Effect of bepridil in patients with chronic stable angina: results of a multicenter trialJ A Hill, J T O'Brien, J S Alpert, et al.

The Journal of Infectious Diseases|June 1, 1994

Alternating nevirapine and zidovudine treatment of human immunodeficiency virus type 1-infected persons does not prolong nevirapine activityM D de Jong, M Loewenthal, C A Boucher, et al.

Pageof 26

Showing results (221-230 of 254) with videos related to

Sort By:

Pageof 26

AIDS (London, England)|April 1, 1993

Antigenic variation of the dominant gp41 epitope in AfricaJ M Lange, V J Teeuwsen, C A Boucher, et al.

AIDS (London, England)|July 24, 1998

Efficient inhibition of both syncytium-inducing and non-syncytium-inducing wild-type HIV-1 by lamivudine in vivoA B van 't Wout, L J Ran, M Nijhuis, et al.

AIDS (London, England)|November 1, 1992

HIV-1 biological phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatmentC A Boucher, J M Lange, F F Miedema, et al.

Antiviral Therapy|April 1, 1996

Tolerability and activity of a new recombinant interferon-alpha B/D hybrid in patients with HIV-1 infectionP H Frissen, K Brinkman, C H Ten Napel, et al.

The American Journal of Cardiology|February 15, 1987

Left ventricular ejection fraction response during exercise in asymptomatic systemic hypertensionD D Miller, T D Ruddy, R M Zusman, et al.

Journal of the American College of Cardiology|March 1, 1986

Determination of the quantitative thallium imaging variables that optimize detection of coronary artery diseaseS Kaul, C A Boucher, J B Newell, et al.

Circulation|August 1, 1981

The effect of pulsatile perfusion on preservation of left ventricular function after aortocoronary bypass graftingF H Levine, H R Phillips, J E Carter, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1980

The bifocal diverging collimator: a means of simultaneous biplane imaging of the heart during equilibrium radionuclide ventriculographyC A Boucher, H W Strauss, R D Okada, et al.

Circulation|January 1, 1985

Effect of bepridil in patients with chronic stable angina: results of a multicenter trialJ A Hill, J T O'Brien, J S Alpert, et al.

The Journal of Infectious Diseases|June 1, 1994

Alternating nevirapine and zidovudine treatment of human immunodeficiency virus type 1-infected persons does not prolong nevirapine activityM D de Jong, M Loewenthal, C A Boucher, et al.

Pageof 26